XP13512 vs. Placebo in Patients With Restless Legs Syndrome.

Clinical trial NCT00365352 · COMPLETED

Trial details

NCT number: NCT00365352
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2006-08-01
Primary completion: 2007-12-01
Enrollment: 325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.